drugset / Trial / NCT03372447

Megadose of Hydroxocobalamin for the Treatment of Pernicious Anemia

NCT03372447

Phase 4 Completed 13 enrolled Hospital Universitario Dr. Jose E. Gonzalez
NaSingle-groupOpen-labelTreatment

Summary

Demonstrate the effectiveness of a single dose of a multivitamin complex for the treatment of megaloblastic anemia

Timeline

Start
2017-12-27
Primary completion
2018-12-01
Completion
2019-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxocobalamin Unknown 10000 ug Intramuscular
Subject Pyridoxine Unknown 50 mg Intramuscular
Subject Thiamine Other / unclassified 100 mg Intramuscular

Indications